WHITEHALL-ROBINS' HAMMONTON, N.J. PLANT HAS HAD THREE FDA INSPECTIONS
This article was originally published in The Tan Sheet
WHITEHALL-ROBINS' HAMMONTON, N.J. PLANT HAS HAD THREE FDA INSPECTIONS in the past 10 months. An inspection conducted in the late summer followed an FDA visit in July and an earlier inspection in January/March. The 1994 agency visits followed at least two inspections the previous year, in February/March and June/July of 1993, which resulted in two warning letters to the company.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC